Matthew R. Cooperberg
- Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Treatment and Research 371
- Prostate Cancer Diagnosis and Treatment 367
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism 45
- Urology top 0.2%
- Oncology top 0.5%
- Global Cancer Incidence and Screening 48
- Rheumatology top 0.2%
- Urologic and reproductive health conditions 37
-
- Bladder and Urothelial Cancer Treatments 69
-
- Statistical Methods in Clinical Trials 36
-
- Health Systems, Economic Evaluations, Quality of Life 29
- Co-authors
- Peter R. CarrollJeanette M. BroeringJanet E. CowanChristopher J. KaneDeborah P. LubeckMaxwell V. MengStephen J. FreedlandS. Mehta
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Matthew R. Cooperberg
503 papers receiving 18.8k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Pulmonary and Respiratory Medicine 15.0k
- Cancer Research 2.6k
- Urology 972
- Oncology 4.0k
- Rheumatology 2.1k
Countries citing papers authored by Matthew R. Cooperberg
This map shows the geographic impact of Matthew R. Cooperberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Cooperberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Cooperberg more than expected).
Fields of papers citing papers by Matthew R. Cooperberg
This network shows the impact of papers produced by Matthew R. Cooperberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Cooperberg. The network helps show where Matthew R. Cooperberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew R. Cooperberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the USbreakdown → | 2023 | 70 |
| 6 | 2023 | 9 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 0 | |
| 11 | 2020 | 13 | |
| 12 | 2017 | 36 | |
| 13 | 2016 | 30 | |
| 14 | 2016 | 14 | |
| 15 | 2015 | 6 | |
| 16 | 2014 | 13 | |
| 17 | 2014 | 119 | |
| 18 | 2013 | 260 | |
| 19 | 2011 | 149 | |
| 20 | 2010 | 219 |
About Matthew R. Cooperberg
Matthew R. Cooperberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Urology, having authored 539 papers that have together received 19.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (371 papers), Prostate Cancer Diagnosis and Treatment (367 papers), Bladder and Urothelial Cancer Treatments (69 papers), Global Cancer Incidence and Screening (48 papers), Cancer, Lipids, and Metabolism (45 papers), Urologic and reproductive health conditions (37 papers), Statistical Methods in Clinical Trials (36 papers) and Health Systems, Economic Evaluations, Quality of Life (29 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (15.0k citations), Cancer Research (2.6k citations) and Urology (972 citations). Matthew R. Cooperberg has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Peter R. Carroll, Jeanette M. Broering, Janet E. Cowan, Christopher J. Kane, Deborah P. Lubeck, Maxwell V. Meng, Stephen J. Freedland, S. Mehta, William J. Aronson and June M. Chan. Their work appears in journals such as New England Journal of Medicine, JAMA and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.